Clinical Trials Directory

Trials / Unknown

UnknownNCT02754414

Cold Apheresis Platelets in PAS

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Bloodworks · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This is a platelet transfusion study. The purpose of this study is to measure the life span and quality of platelets stored in a refrigerator. Participants will give platelets by apheresis. Platelets will be stored for 3 -20 days. A small portion of the subject's own stored platelets will be tagged with a radioactive isotope and infused back into the participant. This will enable us to track how many transfused platelets survive after storage in the refrigerator.

Detailed description

A single hyperconcentrated apheresis platelet unit will be collected from a healthy adult volunteer subject using the Trima Accel® Automated Blood Collection System. Concurrent plasma will be collected. The platelet unit will be stored, not-agitated, for up to 20 days at 4°C in a suspension of 35% plasma and 65% PAS (Platelet Additive Solution). At the end of the storage period, the subject will return to receive an 111Indium Oxine (Indium 111, In-111) radiolabeled aliquot of their 4°C stored platelets. Follow-up samples from the subject will be collected approximately 2 hours post-infusion and on Days 1 (2X), 2 (2X), and 3 to calculate recovery and survival of the subject's 4°C stored platelets. The Day 1 and Day 2 the sample draws will be 2 - 10 hours apart. In addition to radiolabeled platelet recovery and survival measurements, various in vitro assays will be performed on the day of collection at the end of 4°C storage. One week after the infusion of the radiolabeled aliquot, the subject will return to receive a second radiolabeled aliquot of fresh platelets. To facilitate this, on the morning of the second infusion, the subject will return for collection of a 43 mL blood sample. The blood will be processed to obtain a fresh sample of the subject's platelets to serve as a control comparator. The platelets will be radiolabeled with In-111. The subject will return later in the day for infusion of the radiolabeled fresh 'control' comparator aliquot. Follow-up blood samples will be drawn at \~2 hours after the infusion on Day 0 and then on Days 1, 2, 3, 4 or 5, and 6 or 7 day post infusion to calculate recovery and survival of the subject's fresh vs. stored platelets.

Conditions

Interventions

TypeNameDescription
PROCEDUREApheresis platelet collectionA single apheresis platelet unit will be collected from a healthy adult volunteer subject using the Trima Accel® Automated Blood Collection System. Concurrent plasma will be collected.
OTHERRefrigerated storage of apheresis platelets in PAS/plasmaThe apheresis platelet unit will be stored, without agitation, at 4°C, for up to 20 days.
RADIATIONInfusion of aliquot of autologous radiolabeled plateletsFresh and stored aliquots will be labeled with Indium-111. We are administering ≤30 microcuries in both infusions for a total dose of 0.8 mSv.
OTHERIn vitro testsTests to evaluate platelet function will be performed on the platelet unit on day of collection and end of storage

Timeline

Start date
2016-04-01
Primary completion
2018-12-01
Completion
2019-01-01
First posted
2016-04-28
Last updated
2018-05-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02754414. Inclusion in this directory is not an endorsement.